Filtered By:
Infectious Disease: Ebola
This page shows you your search results in order of relevance. This is page number 15.
Order by Relevance | Date
Total 8249 results found since Jan 2013.
Differential Diagnosis of Illness in Travelers Arriving From Sierra Leone, Liberia, or Guinea: A Cross-sectional Study From the GeoSentinel Surveillance Network.
Conclusion: Although EVD may currently drive clinical evaluation of ill travelers arriving from Sierra Leone, Liberia, and Guinea, clinicians must be aware of other more common, potentially fatal diseases. Malaria remains a common diagnosis among travelers seen at GeoSentinel sites. Prompt exclusion of malaria and other life-threatening conditions is critical to limiting morbidity and mortality.
Primary Funding Source: Centers for Disease Control and Prevention.
PMID: 25961811 [PubMed - as supplied by publisher]
Source: Annals of Internal Medicine - May 12, 2015 Category: Internal Medicine Authors: Boggild AK, Esposito DH, Kozarsky PE, Ansdell V, Beeching NJ, Campion D, Castelli F, Caumes E, Chappuis F, Cramer JP, Gkrania-Klotsas E, Grobusch MP, F Hagmann SH, Hynes NA, Lim PL, López-Vélez R, M Malvy DJ, Mendelson M, Parola P, Sotir MJ, Wu HM, Hame Tags: Ann Intern Med Source Type: research
Emergency Department Processes for the Evaluation and Management of Persons Under Investigation for Ebola Virus Disease
Conclusion ED processes for the safe and timely evaluation and management of the person under investigation for Ebola virus disease are presented with the ultimate goals of protecting providers and ensuring a consistent level of care while confirmatory testing is pending.
Source: Annals of Emergency Medicine - May 23, 2015 Category: Emergency Medicine Source Type: research
Transport and Management of Patients With Confirmed or Suspected Ebola Virus Disease
The objectives of these hospital and out-of-hospital collaborations were to close education, training, and practice gaps to best facilitate the care for patients with serious communicable disease while ensuring the safety of the medics and the general public through meticulous implementation of infection control practices as recommended by Centers for Disease Control and Prevention. The description of practices implemented by EMS teams in these communities for the transport of patients with confirmed Ebola virus disease is shared so that others might more readily implement these practices, policies, and procedures as appli...
Source: Annals of Emergency Medicine - May 23, 2015 Category: Emergency Medicine Source Type: research
Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain
This report emphasises the uncertainties about the efficacy of experimental treatments for Ebola virus disease. Clinicians should be aware of the possibility of transfusion-related acute lung injury when using convalescent plasma for the treatment of Ebola virus disease. Funding La Paz-Carlos III University Hospital.
Source: The Lancet Respiratory Medicine - June 1, 2015 Category: Respiratory Medicine Source Type: research
Erratum: Brief Report: Persistence of Ebola Virus in Ocular Fluid during Convalescence
New England Journal of Medicine, Ahead of Print.
Source: New England Journal of Medicine - June 1, 2015 Category: Internal Medicine Tags: article Source Type: research
Drugs to fight Ebola may already be in your medicine cabinet, study suggests
Researchers have found two drugs that saved the lives of mice infected with the deadly Ebola virus, and you may have them in your medicine cabinet already.
Source: Los Angeles Times - Science - June 3, 2015 Category: Science Source Type: news
Shedding of Ebola Virus in an Asymptomatic Pregnant Woman
New England Journal of Medicine, Volume 372, Issue 25, Page 2467-2469, June 2015.
Source: New England Journal of Medicine - June 17, 2015 Category: Internal Medicine Tags: article Source Type: research
Drugs to fight Ebola may already be in your medicine cabinet, study suggests
Researchers have found two drugs that saved the lives of mice infected with the deadly Ebola virus, and you may have them in your medicine cabinet already.
Source: Los Angeles Times - Science - June 3, 2015 Category: Science Authors: Karen Kaplan Source Type: news
Diagnostic performances of clinical laboratory tests using Triton X-100 to reduce the biohazard associated with routine testing of Ebola virus-infected patients
Journal Name: Clinical Chemistry and Laboratory Medicine (CCLM)Issue: Ahead of print
Source: Clinical Chemistry and Laboratory Medicine - June 26, 2015 Category: Laboratory Medicine Source Type: research
The challenges of treating Ebola virus disease with experimental therapies
Publication date: July 2015 Source:The Lancet Respiratory Medicine, Volume 3, Issue 7 Author(s): Kazuyoshi Aoyama , Robert A Fowler
Source: The Lancet Respiratory Medicine - July 6, 2015 Category: Respiratory Medicine Source Type: research
Resurgence of Ebola virus disease in Liberia
Publication date: Available online 9 July 2015 Source:The Lancet Respiratory Medicine Author(s): Talha Khan Burki
Source: The Lancet Respiratory Medicine - July 11, 2015 Category: Respiratory Medicine Source Type: research
Triage in the Time of Ebola: Research Across the Plexiglas Partition
Publication date: Available online 26 July 2015 Source:Annals of Emergency Medicine Author(s): Matthew Waxman
Source: Annals of Emergency Medicine - July 26, 2015 Category: Emergency Medicine Source Type: research
Ebola in the United States — Public Reactions and Implications
New England Journal of Medicine, Ahead of Print.
Source: New England Journal of Medicine - July 29, 2015 Category: Internal Medicine Tags: article Source Type: research
Community Trust and the Ebola Endgame
New England Journal of Medicine, Ahead of Print.
Source: New England Journal of Medicine - July 29, 2015 Category: Internal Medicine Tags: article Source Type: research
Guinea: The Ebola Vaccine - Seven Things to Understand About rVSV-ZEBOV
[Ebola Deeply] A trial of the rVSV-ZEBOV Ebola vaccine among 7,651 individuals in Guinea has been found to have a protection rate of 100 percent. The vaccine was developed by Merck, the Wellcome Trust and the governments of Norway and Canada, in conjunction with MSF and the London School of Hygiene and Tropical Medicine. Public health experts are calling for the vaccine to be rolled out immediately.
Source: AllAfrica News: Health and Medicine - August 4, 2015 Category: African Health Source Type: news
